How much is Obsidian Therapeutics worth in 2026?

Obsidian Therapeutics has a current valuation of N/A based on their Later Stage VC (Series C) round and secondary market data.

How much funding has Obsidian Therapeutics raised?

Obsidian Therapeutics has raised N/A in total funding across 2 funding rounds.

Obsidian Therapeutics

Drug Discovery

Obsidian Therapeutics valuation and funding history | Last updated: March 27, 2024 | 2 funding rounds

Current Valuation

N/A

As of March 27, 2024

Total Funding Raised

N/A

Across 2 rounds

Last Round

Later Stage VC (Series C)

$160.5M

Last Funding

Mar 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
March 27, 2024	Later Stage VC (Series C)	$160.5M	N/A	-
September 9, 2021	Later Stage VC (Series B)	$115.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Obsidian Therapeutics is currently valued at N/A as of March 27, 2024.

Track Obsidian Therapeutics Valuation Updates

Get notified when Obsidian Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Obsidian Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Obsidian Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Obsidian Therapeutics Worth in 2026?

Obsidian Therapeutics is a leading private company in the Drug Discovery sector. Track Obsidian Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Obsidian Therapeutics Valuation is Determined

Private company valuations like Obsidian Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.